Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
0
In m-ccRCC patients with PM, first-line therapy with VEGFR-TKIs or ICPI/VEGFR-TKI-combinations leads to improved RR and tumor shrinkage, compared to ipilimumab/nivolumab, but not to CSS benefit in the current analysis.